Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GMAB
GMAB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GMAB News
Genmab Major Shareholder Announcement
6d ago
Newsfilter
Genmab's DARZALEX Global Sales Reach $3.96 Billion
6d ago
seekingalpha
Genmab Reports $3.964 Billion DARZALEX® Sales in Q1 2026
6d ago
Newsfilter
Safety Study of Rina-S and Bevacizumab Combination Therapy
Apr 13 2026
Newsfilter
Corbus Secures FDA Alignment on CRB-701 Pathway
Apr 07 2026
Newsfilter
Genmab Major Shareholder Announcement
Mar 30 2026
Newsfilter
Investment Opportunities in Oversold Healthcare Stocks
Feb 19 2026
Benzinga
Genmab Initiates Share Buyback Program
Feb 18 2026
NASDAQ.COM
Genmab Reports FY 2025 Earnings Highlights
Feb 18 2026
seekingalpha
Genmab Releases 2025 Annual Report and Outlook
Feb 17 2026
Newsfilter
BioNJ Elects New Board Officers and Members
Feb 12 2026
Yahoo Finance
Oncolytics Biotech Strengthens Leadership Amid FDA Approval Surge
Jan 30 2026
PRnewswire
Oncolytics Biotech Strengthens Leadership Amid FDA Approval Surge
Jan 30 2026
Newsfilter
Alphabet and Nvidia Lead AI Investment Wave, AbbVie and IBKR Show Long-Term Resilience
Jan 22 2026
NASDAQ.COM
2026 Investment Outlook: Four Stocks with Compounding Potential
Jan 22 2026
Fool
Genmab's DARZALEX Sales Reach $14.35 Billion in 2025, Continuing Growth
Jan 21 2026
NASDAQ.COM
Show More News
